Optogenetics
Market, By Sensors (pH Sensors, Genetically Modified Calcium Indicators,
Neurotransmitter Release, and Voltage-sensitive Fluorescent Proteins), By
Technique (Channelrhodopsin, Halorhodopsin, and Archaerhodopsin), By
Application (Retinal Disease Treatment, Cardiovascular Ailments, Neuroscience,
Behavioral Tracking, and Pacing), and By Light Equipment (Lasers, LEDs, and
Others) - Global Industry Insights, Trends, Outlook, And Opportunity Analysis,
2018-2026
Optogenetics is an emerging
medical technique, which involves the use of light to control cells in living
tissues, especially neurons to help study the characteristics of normal and
abnormal brain function. Optogenetics is an emerging field of biotechnology
trending among the fields of neuroscience, cardiology, ophthalmology,
behavioral science, and other healthcare domains. The technique is widely used
to treat neurological disorders such as depression. Depression is caused by
chronic stress that causes a series of negative memories. Optogenetics
technology is used by placing the genes that express light-sensitive proteins
into mammalian cells, which normally lack such proteins. When the proteins are
illuminated with specific wavelengths of light, they change the behavior of the
cells, thereby introducing certain types of ions or pushing out a few to alter
electrical activity. Furthermore, optogenetics has also been used in the
treatment of retinal disease and hearing impairment. Advancements in
optogenetics technology has led to a sound understanding of neuroscience.
Presently, multiphoton excitation microscopy is the technique that is used for
investigating optogenetic studies of live animal brain at single neuron
resolution.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1097
Wireless microchips emerging as a
new technology in optogenetics is expected to boost market growth
The major factor contributing to
growth of the global optogenetics market is the rising use of optogenetics in
the field of neuroscience. New developments in optogenetics such as wireless
microchips have enabled convenient treatment of conditions, including
depression and Parkinson’s disease. According to World Health Organization
(WHO) in 2017, it is estimated around 300 million people were affected by
depression globally which makes it the main cause of disability such as
decrease in self-esteem, feeling bored and loss of a direction or purpose . Furthermore, rampant advancements in
technology such as ultrafast laser tools, LEDs, ytterbium-based lasers are the
other factors responsible in driving the growth of optogenetics market.
However, reluctance in adoption of new technology by healthcare professionals
due to high costs in the deployment of technology, lack of awareness regarding
the tools in emerging economies, and lack of availability of genetic reagents
that can be conveniently used for probing biological processes are factors
hindering growth of the optogenetics market.
On the basis of region,
optogenetics market is segmented into North America, Latin America, Europe,
Asia Pacific, Middle East, and Africa. North America is expected to hold the
dominant position in the optogenetics market, owing to the rising demand for
light therapy treatment for chronic pain in the region.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/optogenetics-market-1097
For instance, According to
Montreal Neurological Institute, the light treatment therapy has the ability to
control virtually any type of neuron in the brain with pulses of light, thus
making it precise both, in terms of timing and type of cells affected. Thus,
optogenetics has proved to have a much more targeted approach to chronic pain
relief than the conventional methods, which cannot be localized with the same
precision as a beam of light. Furthermore, Asia Pacific is expected to hold a
major market share in the global optogenetics market during the forecast
period, primarily attributed to increasing adoption of optogenetic techniques
and ultrafast laser tools by several neuroscience labs.
Growing application areas for
optogenetics is expected to propel market growth
Key players in the optogenetics
market include Coherent, Inc., Thorlabs, Inc. Cobalt, Inc., Scientifica,
Laserglow Technologies, Regenxbio, Inc., Gensight, Addgene, UPenn Vector Core,
and Jackson Laboratories. The key players are focusing on strategic mergers and
acquisitions and development of innovative systems. For instance, Coherent Inc.
launched a new type of short pulse ultrafast laser sources that provides wide
wavelength (680-1300nm) tunability of the primary output as well as
simultaneous high power (1.5 watts) output at 1040 nm. Furthermore, this
combination makes lasers such as Chameleon Discovery ideal for demanding
multiphoton excitation application in optogenetics.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1097
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment